# Effect of Anti-IgE in Chronic Urticaria

> **NCT00130234** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 20 (—)

## Conditions studied

- Urticaria

## Interventions

- **DRUG:** Xolair® (Omalizumab)

## Key facts

- **NCT ID:** NCT00130234
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 20 (—)
- **Last updated:** 2008-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00130234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00130234, "Effect of Anti-IgE in Chronic Urticaria". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00130234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*